Loading clinical trials...
Loading clinical trials...
A growing body of evidence suggests patients with late-onset seizures are at an increased risk of stroke, but the potential for reducing cardiovascular morbidity through risk factor screening and management is unknown. The investigators aim to determine whether individuals with new-onset unprovoked seizures after middle age should undergo vascular risk assessment. In a cluster project the investigators assess the effect of vascular risk factor screening in an observational study as well as a cohort study. The project has two interlinked components: a prospective single group study, in which risk factor assessment is performed and subsequent management is followed for one year; and a register-based cohort study examining the long-term effects of the intervention on a system level.
Cluster design: Participating sites start with vascular risk factor intervention - patients are then offered participation in an observational 1-year study. In addition, all patients at the sites are followed in registers and compared to historic controls. Follow-up in the register study will be at least 5, but probably 10 years (until significant difference in primary analysis - Kaplan Meier).
Age
50 - No limit years
Sex
ALL
Healthy Volunteers
No
Södra Älvsborg Sjukhus
Borås, Sweden
Salgrenska University Hospital
Gothenburg, Sweden
Skånes universitetssjukhus
Malmo, Sweden
Start Date
September 1, 2025
Primary Completion Date
December 1, 2027
Completion Date
June 1, 2035
Last Updated
March 3, 2026
420
ESTIMATED participants
Vascuar risk factor screening (blood pressure, medical history, BMI, laboratory tests)
OTHER
Lead Sponsor
Sahlgrenska University Hospital
Collaborators
NCT06700356
NCT05077904
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05667142